Literature DB >> 27837280

Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome.

Félix Javier Jiménez-Jiménez1,2, Elena García-Martín3, Hortensia Alonso-Navarro4,5, Carmen Martínez6, Martín Zurdo7, Laura Turpín-Fenoll8, Jorge Millán-Pascual8, Teresa Adeva-Bartolomé9, Esther Cubo10, Francisco Navacerrada4, Ana Rojo-Sebastián5, Lluisa Rubio5, Sara Ortega-Cubero11,12,13, Pau Pastor11,12,13,14, Marisol Calleja4, José Francisco Plaza-Nieto4, Belén Pilo-de-la-Fuente4, Margarita Arroyo-Solera4, Esteban García-Albea5, José A G Agúndez3.   

Abstract

A recent meta-analysis suggests an association between the rs11558538 single nucleotide polymorphism in the histamine-N-methyl-transferase (HNMT) gene and the risk for Parkinson's disease. Based on the possible relationship between PD and restless legs syndrome (RLS), we tried to establish whether rs11558538 SNP is associated with the risk for RLS. We studied the genotype and allelic variant frequencies of HNMT rs11558538 SNP 205 RLS patients and 410 healthy controls using a TaqMan assay. The frequencies of the HNMT rs11558538 genotypes allelic variants were similar between RLS patients and controls, and were not influenced by gender, family history of RLS, or RLS severity. RLS patients carrying the genotype rs11558538TT had an earlier age at onset, but this finding was based on three subjects only. These results suggest a lack of major association between HNMT rs11558538 SNP and the risk for RLS.

Entities:  

Keywords:  Genetics; HNMT gene; Polymorphisms; Restless legs syndrome; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 27837280     DOI: 10.1007/s00702-016-1645-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  32 in total

1.  Restless legs syndrome and Parkinson's disease in men.

Authors:  Xiang Gao; Michael A Schwarzschild; Eilis J O'Reilly; Hao Wang; Alberto Ascherio
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Authors:  Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee
Journal:  Sleep Med       Date:  2014-05-17       Impact factor: 3.492

3.  Interaction Between Brain Histamine and Serotonin, Norepinephrine, and Dopamine Systems: In Vivo Microdialysis and Electrophysiology Study.

Authors:  Gunnar Flik; Joost H A Folgering; Thomas I H F Cremers; Ben H C Westerink; Eliyahu Dremencov
Journal:  J Mol Neurosci       Date:  2015-03-29       Impact factor: 3.444

4.  Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma.

Authors:  L Yan; R E Galinsky; J A Bernstein; S B Liggett; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  2000-04

5.  Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice.

Authors:  Yasuhiko Kubota; Chihiro Ito; Eiichi Sakurai; Eiko Sakurai; Takehiko Watanabe; Hiroshi Ohtsu
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

6.  Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis.

Authors:  E García-Martín; C Martínez; J Benito-León; P Calleja; M Díaz-Sánchez; D Pisa; H Alonso-Navarro; L Ayuso-Peralta; D Torrecilla; J A G Agúndez; F J Jiménez-Jiménez
Journal:  Eur J Neurol       Date:  2009-06-15       Impact factor: 6.089

7.  Restless legs syndrome: an early clinical feature of Parkinson disease in men.

Authors:  Janice C Wong; Yanping Li; Michael A Schwarzschild; Alberto Ascherio; Xiang Gao
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

Review 8.  Histamine H₃ receptors, the complex interaction with dopamine and its implications for addiction.

Authors:  B A Ellenbroek
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

Review 10.  Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more
  2 in total

1.  Reassessment of candidate gene studies for idiopathic restless legs syndrome in a large genome-wide association study dataset of European ancestry.

Authors:  Barbara Schormair; Chen Zhao; Aaro V Salminen; Konrad Oexle; Juliane Winkelmann
Journal:  Sleep       Date:  2022-08-11       Impact factor: 6.313

2.  Common Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphisms are not Related With the Risk for Restless Legs Syndrome.

Authors:  Félix Javier Jiménez-Jiménez; Blanca G Agúndez; Javier Gómez-Tabales; Hortensia Alonso-Navarro; Laura Turpín-Fenoll; Jorge Millán-Pascual; Mónica Díez-Fairén; Ignacio Álvarez; Pau Pastor; Marisol Calleja; Rafael García-Ruiz; Santiago Navarro-Muñoz; Marta Recio-Bermejo; José Francisco Plaza-Nieto; Esteban García-Albea; Elena García-Martín; José A G Agúndez
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.